Literature DB >> 19652956

Cognitive enhancing effects of ghrelin receptor agonists.

Zeenat Atcha1, Woei-Shin Chen, Agnes B Ong, Fong-Kuan Wong, Aveline Neo, Edward R Browne, Jason Witherington, Darrel J Pemberton.   

Abstract

RATIONALE: Ghrelin, the endogenous ligand for the growth hormone secretagogue receptor, has been shown to play a role in multiple physiological processes including appetite regulation, metabolism and, more recently, dendritic spine architecture, long-term potentiation and cognition.
OBJECTIVE: The objective of this study was to determine the effects of two structurally non-peptide ghrelin receptor agonists (GSK894490A and CP-464709-18) on rodent cognition.
METHODS: All experiments were performed in male Lister hooded rats. Effects of the test compounds on rat cognitive performance was determined using the novel object recognition test, a modified water maze paradigm and a scopolamine-induced deficit in cued fear conditioning. These tests were chosen as they each probe a relatively independent cognitive domain and therefore potentially have differing underlying neural substrates.
RESULTS: Both compounds significantly improved performance in the novel object recognition and modified water maze tests but were unable to attenuate a scopolamine deficit in cued fear conditioning.
CONCLUSIONS: These results demonstrate that the small-molecule ghrelin receptor agonists profiled here readily cross the blood/brain barrier and elicit pro-cognitive effects in recognition and spatial learning and memory tests. Based on these observations, the central ghrelin receptor would appear to be a chemically tractable receptor and perhaps should be considered as a new drug target for therapeutic approaches to treat diseases affecting cognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652956     DOI: 10.1007/s00213-009-1620-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  The Atlantis platform: a new design and further developments of Buresova's on-demand platform for the water maze.

Authors:  R I Spooner; A Thomson; J Hall; R G Morris; S H Salter
Journal:  Learn Mem       Date:  1994 Sep-Oct       Impact factor: 2.460

2.  Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.

Authors:  L C Pan; P A Carpino; B A Lefker; J A Ragan; S M Toler; J C Pettersen; D O Nettleton; O Ng; C M Pirie; K Chidsey-Frink; B Lu; D F Nickerson; D A Tess; M A Mullins; D B MacLean; P A DaSilva-Jardine; D D Thompson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

3.  Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.

Authors:  Jason Witherington; Lee Abberley; Michael A Briggs; Katharine Collis; David K Dean; Alessandra Gaiba; N Paul King; Helmut Kraus; Nicola Shuker; Jon G A Steadman; Andrew K Takle; Gareth Sanger; Graham Wadsworth; Sharon Butler; Fiona McKay; Alison Muir; Kim Winborn; Tom D Heightman
Journal:  Bioorg Med Chem Lett       Date:  2007-12-15       Impact factor: 2.823

4.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 5.  Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor.

Authors:  M Kojima; H Hosoda; K Kangawa
Journal:  Horm Res       Date:  2001

Review 6.  Ghrelin: structure and function.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

7.  Ghrelin gastrokinetic action in patients with neurogenic gastroparesis.

Authors:  M Binn; C Albert; A Gougeon; H Maerki; B Coulie; M Lemoyne; R Rabasa Lhoret; C Tomasetto; P Poitras
Journal:  Peptides       Date:  2006-01-19       Impact factor: 3.750

8.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

9.  The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress.

Authors:  Michael Lutter; Ichiro Sakata; Sherri Osborne-Lawrence; Sherry A Rovinsky; Jason G Anderson; Saendy Jung; Shari Birnbaum; Masashi Yanagisawa; Joel K Elmquist; Eric J Nestler; Jeffrey M Zigman
Journal:  Nat Neurosci       Date:  2008-06-15       Impact factor: 24.884

10.  Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Authors:  A A Patchett; R P Nargund; J R Tata; M H Chen; K J Barakat; D B Johnston; K Cheng; W W Chan; B Butler; G Hickey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more
  24 in total

1.  Alternative method of oral dosing for rats.

Authors:  Zeenat Atcha; Claire Rourke; Aveline Hp Neo; Catherine Wh Goh; Jean Sk Lim; Chiu-Cheong Aw; Edward R Browne; Darrel J Pemberton
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

2.  Recombinant adenovirus-mediated expression of GHS-R1a in HEK 293 cells.

Authors:  Li Liu; Hua-Min Xu; Hong Jiang; Jun Wang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 3.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

4.  Short-term improvements in cognitive function following vertical sleeve gastrectomy and Roux-en Y gastric bypass: a direct comparison study.

Authors:  Kimberly R Smith; Timothy H Moran; Afroditi Papantoni; Caroline Speck; Arnold Bakker; Vidyulata Kamath; Susan Carnell; Kimberley E Steele
Journal:  Surg Endosc       Date:  2019-07-31       Impact factor: 4.584

5.  Growth hormone secretagogue receptor constitutive activity impairs voltage-gated calcium channel-dependent inhibitory neurotransmission in hippocampal neurons.

Authors:  Valentina Martínez Damonte; Silvia Susana Rodríguez; Jesica Raingo
Journal:  J Physiol       Date:  2018-10-14       Impact factor: 5.182

Review 6.  Obesity-associated biomarkers and executive function in children.

Authors:  Alison L Miller; Hannah J Lee; Julie C Lumeng
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

7.  Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors.

Authors:  P Shane Clifford; Juan Rodriguez; Destri Schul; Samuel Hughes; Tracey Kniffin; Nigel Hart; Shoshana Eitan; Luc Brunel; Jean-Alain Fehrentz; Jean Martinez; Paul J Wellman
Journal:  Addict Biol       Date:  2011-07-25       Impact factor: 4.280

8.  Relationship between gut and sepsis: Role of ghrelin.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-01-15

9.  Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats.

Authors:  Paul J Wellman; P Shane Clifford; Juan Rodriguez; Samuel Hughes; Shoshana Eitan; Luc Brunel; Jean-Alain Fehrentz; Jean Martinez
Journal:  Regul Pept       Date:  2011-09-06

10.  Ghrelin triggers the synaptic incorporation of AMPA receptors in the hippocampus.

Authors:  Luís F Ribeiro; Tatiana Catarino; Sandra D Santos; Marion Benoist; J Fiona van Leeuwen; José A Esteban; Ana Luísa Carvalho
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.